Simplify Health Care ETF Rating $30.08 -0.61 (-1.99%) (As of 11/15/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings Simplify Health Care ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PINK Aggregate RatingModerate Buy2.71Holdings in PINK have an aggregate rating of Moderate Buy based on 760 analyst ratings issued in the past year covering 49 companies (97.1% of the portfolio).PINK Aggregate Price Target$30.08High Prediction$30.08Average Prediction$30.08Low Prediction$30.08Holdings in PINK have an aggregate price target of $30.08 and a range of $30.08 to $30.08 covering 49 companies (97.1% of the portfolio).PINK Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy35 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 PINK Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.53%PCTPureCycle Technologies$11.04-0.9%1.6689 of 5 stars2.50$9.60 -13.0%6Analyst ForecastPositive News6.57%LLYEli Lilly and Company$746.20-4.9%4.9836 of 5 stars2.81$1,007.94 35.1%21Analyst ForecastNews CoveragePositive News6.53%JNJJohnson & Johnson$154.00+1.4%4.9673 of 5 stars2.53$175.94 14.2%15Analyst ForecastNews CoveragePositive News5.12%ISRGIntuitive Surgical$527.61-1.9%4.5913 of 5 stars2.67$524.61 -0.6%18Insider SellingShort Interest ↑News CoveragePositive News4.93%UNHUnitedHealth Group$592.23-0.2%4.9352 of 5 stars2.95$615.53 3.9%22Analyst UpgradeAnalyst RevisionNews CoveragePositive News4.63%VRTXVertex Pharmaceuticals$465.70-3.8%3.5494 of 5 stars2.53$499.12 7.2%30Analyst UpgradeNews CoveragePositive NewsHigh Trading Volume4.61%SNYSanofi$47.97+0.3%2.8526 of 5 stars2.75$57.50 19.9%4Analyst Revision4.31%RMDResMed$234.74+1.4%4.7269 of 5 stars2.50$225.70 -3.9%12Insider SellingAnalyst RevisionNews CoveragePositive News3.89%CIThe Cigna Group$321.52-0.7%4.9775 of 5 stars3.00$394.64 22.7%15Short Interest ↑3.74%SRPTSarepta Therapeutics$104.54-4.2%4.929 of 5 stars3.00$181.33 73.5%22Analyst Upgrade3.71%GILDGilead Sciences$88.40-4.0%4.6269 of 5 stars2.68$93.86 6.2%25Analyst UpgradeShort Interest ↑News Coverage3.60%TNDMTandem Diabetes Care$27.34-4.4%4.5893 of 5 stars2.78$54.25 98.4%183.39%REGNRegeneron Pharmaceuticals$756.81-3.3%4.8088 of 5 stars2.78$1,099.55 45.3%23Analyst UpgradeNews Coverage3.30%TMOThermo Fisher Scientific$513.08-3.7%4.9932 of 5 stars2.86$649.33 26.6%22Insider SellingBuyback AnnouncementAnalyst RevisionNews CoveragePositive NewsHigh Trading Volume3.07%EWEdwards Lifesciences$67.76+2.4%4.5539 of 5 stars2.38$75.67 11.7%26Insider SellingShort Interest ↓Analyst Revision2.38%ADMAADMA Biologics$19.04-5.7%3.6298 of 5 stars3.25$21.25 11.6%4Gap Up2.29%CHWYChewy$31.71-2.1%3.8617 of 5 stars2.55$30.15 -4.9%22Short Interest ↓Gap Up2.13%MMM3M$129.79-1.4%4.8827 of 5 stars2.56$144.87 11.6%16Analyst UpgradePositive News2.02%MYGNMyriad Genetics$15.25-2.7%4.3033 of 5 stars2.42$28.36 86.0%12Analyst UpgradeNews Coverage1.94%CASHPathward Financial$79.63-0.5%2.5655 of 5 stars2.50$74.50 -6.4%2Insider SellingShort Interest ↓1.69%TFXTeleflex$192.15+0.9%4.9121 of 5 stars2.67$259.25 34.9%9Analyst Upgrade1.60%LPTXLeap Therapeutics$2.74-5.2%2.3568 of 5 stars3.00$8.63 214.8%4Analyst ForecastShort Interest ↑News Coverage1.31%RVTYRevvity$109.52-5.6%3.9523 of 5 stars2.65$132.07 20.6%17Positive News1.18%ITCIIntra-Cellular Therapies$83.42-4.8%4.5171 of 5 stars2.85$97.23 16.6%13Insider SellingPositive News1.11%RPRXRoyalty Pharma$25.70+1.3%4.7879 of 5 stars2.83$41.67 62.1%6Positive News0.89%EXASExact Sciences$49.33-3.1%4.862 of 5 stars2.95$74.47 51.0%19Insider BuyingShort Interest ↓0.88%IQVIQVIA$192.68-5.1%4.9877 of 5 stars2.84$259.13 34.5%19News CoveragePositive NewsHigh Trading Volume0.77%AKROAkero Therapeutics$28.09-5.6%4.0411 of 5 stars2.86$43.20 53.8%7Earnings ReportShort Interest ↓Analyst RevisionNews Coverage0.71%ABTAbbott Laboratories$115.90+0.8%4.9788 of 5 stars2.75$130.07 12.2%16News CoveragePositive News0.63%ARGXargenx$564.23-5.2%2.8645 of 5 stars2.91$619.79 9.8%23Analyst UpgradeGap DownHigh Trading Volume0.51%BNTCBenitec Biopharma$10.68+2.7%2.3142 of 5 stars3.17$22.60 111.6%6Short Interest ↑News Coverage0.50%FULCFulcrum Therapeutics$3.01-9.4%3.4539 of 5 stars2.20$9.33 210.6%10Analyst ForecastAnalyst RevisionNews Coverage0.44%ESTAEstablishment Labs$37.79+0.7%2.1991 of 5 stars2.80$60.60 60.4%50.40%COOCooper Companies$99.63-0.2%3.5123 of 5 stars2.75$117.00 17.4%12Analyst UpgradeShort Interest ↑News Coverage0.35%SNDXSyndax Pharmaceuticals$15.83-5.7%3.4713 of 5 stars2.91$36.00 127.4%11Analyst ForecastNews CoverageHigh Trading Volume0.30%LIVNLivaNova$52.10-0.4%4.0253 of 5 stars3.00$69.17 32.8%7Analyst ForecastNews Coverage0.29%SYKStryker$390.08+1.8%4.9557 of 5 stars2.80$393.65 0.9%20Analyst UpgradeNews CoveragePositive NewsHigh Trading Volume0.27%CVSCVS Health$53.19-3.4%4.9993 of 5 stars2.60$72.44 36.2%20Analyst DowngradeShort Interest ↑0.25%TECHBio-Techne$67.57-6.9%4.7403 of 5 stars2.67$81.78 21.0%9Analyst UpgradeHigh Trading Volume0.24%BMRNBioMarin Pharmaceutical$63.42-3.3%4.987 of 5 stars2.74$94.20 48.5%23Analyst ForecastInsider SellingNews Coverage0.22%DHRDanaher$230.50-3.7%4.9482 of 5 stars2.74$287.16 24.6%19Analyst RevisionNews CoveragePositive News0.20%AGLagilon health$1.58-7.6%2.3329 of 5 stars1.95$6.38 304.0%20Analyst ForecastAnalyst Revision0.18%BIIBBiogen$159.99-3.0%4.8908 of 5 stars2.57$258.96 61.9%28Analyst UpgradeNews Coverage0.17%HSICHenry Schein$68.76+3.3%4.0574 of 5 stars2.64$78.89 14.7%11Short Interest ↑0.16%ZBHZimmer Biomet$112.54+3.4%4.3575 of 5 stars2.20$123.22 9.5%20Short Interest ↑News CoveragePositive News0.04%BSXBoston Scientific$86.99-0.7%4.4741 of 5 stars2.91$93.39 7.4%23Short Interest ↑News Coverage0.03%VLTOVeralto$102.68-0.4%2.3099 of 5 stars2.42$108.27 5.4%12Positive News0.02%BMYBristol-Myers Squibb$56.22-3.9%4.7896 of 5 stars2.20$54.07 -3.8%20Analyst ForecastAnalyst RevisionNews Coverage0.02%INSMInsmed$66.29-7.0%4.3872 of 5 stars3.00$83.07 25.3%16Positive NewsHigh Trading Volume This page (NYSEARCA:PINK) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Simplify Health Care ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PINK Stock Alerts